Abstract
Lung disease caused by Mycobacterium abscessus is increasing, and current clarithromycin-based treatment regimens are only moderately effective. Here, we determined the effect of clarithromycin-vancomycin combination against M. abscessus complex isolates in vitro . Synergy was found with a fractional inhibitory concentration index (FICI) score of ≤0.5 and a 4- to 10-fold decrease in MIC.
Funding Information
  • National Medical Research Council Singapore (NMRC/TCR/011-NUHS/2014)

This publication has 20 references indexed in Scilit: